Form 4: AtriCure Director Maggie Yuen Reports Acquisition and Disposal of Common Stock

Director Maggie Yuen reports acquiring 7,788 shares of AtriCure common stock through a restricted stock award and disposing of 12,470 shares.

Summary

• On May 13, 2024, Maggie Yuen, a director of AtriCure, Inc., reported a transaction involving the company's common stock.
• Yuen acquired 7,788 shares through a restricted stock award under the 2023 Stock Incentive Plan.
• These shares will vest one year from the grant date.
• Yuen also disposed of 12,470 shares.
• Following these transactions, Yuen beneficially owns 12,470 shares of AtriCure common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports transactions without providing explicit positive or negative commentary. The acquisition through a stock award is mildly positive, while the disposal is mildly negative, balancing each other out.

Positives

• The acquisition of shares via a restricted stock award aligns the director's interests with the company's long-term performance.

Negatives

• The disposal of 12,470 shares could be interpreted negatively by investors, although the reason for disposal is not specified.

Risks

• The disposal of shares by a director could potentially signal a lack of confidence in the company's future performance, although this is not explicitly stated.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company insiders.

Stakeholder Impact

• Shareholders may be interested in the director's stock transactions as an indicator of company performance and insider confidence.

Key Dates